Literature DB >> 6186874

Treatment of advanced primary hepatocellular carcinoma by 131-I-anti-AFP.

Y K Liu, K Z Yang, Y D Wu, Y Q Gang, D N Zhu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6186874     DOI： 10.1016/s0140-6736(83)92220-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma.

Authors:  Y D Wu; K Z Yang; D N Zhou; Y Q Gang; X Q Song; X H Hu; B Y Huang
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.